The accession number was GSE32988, providing 62 pre-chemotherapy biopsies of HER2 normal breast cancer patients (ER-positive and ER-negative subtypes) with the results of the TAM-chemotherapy. This evidence concerns the gene ERBB2 and breast carcinoma.